434 results on '"Kang, Moo Il"'
Search Results
152. Relationship between Subclinical Thyroid Dysfunction and Femoral Neck Bone Mineral Density in Women
- Author
-
Lee, Won Young, primary, Oh, Ki Won, additional, Rhee, Eun Jung, additional, Jung, Chan Hee, additional, Kim, Sun Woo, additional, Yun, Eun Joo, additional, Tae, Hyun Jung, additional, Baek, Ki Hyun, additional, Kang, Moo Il, additional, Choi, Moon Gi, additional, Yoo, Hyung Joon, additional, and Park, Sung Woo, additional
- Published
- 2006
- Full Text
- View/download PDF
153. The length of CpG islands is associated with the distribution of Alu and L1 retroelements
- Author
-
Kang, Moo-Il, primary, Rhyu, Mun-Gan, additional, Kim, Young-Ho, additional, Jung, Yu-Chae, additional, Hong, Seung-Jin, additional, Cho, Chul-Soo, additional, and Kim, Hye-Soo, additional
- Published
- 2006
- Full Text
- View/download PDF
154. Effects of Two Common Polymorphisms of Peroxisome Proliferator-Activated Receptor-γ Gene on Metabolic Syndrome
- Author
-
Rhee, Eun Jung, primary, Oh, Ki Won, additional, Lee, Won Young, additional, Kim, Se Yeon, additional, Oh, Eun Sook, additional, Baek, Ki Hyun, additional, Kang, Moo Il, additional, and Kim, Sun Woo, additional
- Published
- 2006
- Full Text
- View/download PDF
155. The Effect of Oxidative Stress on the Proliferation and Differentiation of Human Bone Marrow Stromal Cell-Derived Osteoblasts
- Author
-
Oh, Eun Sook, primary, Baek, Ki Hyun, additional, Lee, Won Young, additional, Oh, Ki Won, additional, Kim, Hye Soo, additional, Han, Je Ho, additional, Lee, Kwang Woo, additional, Son, Ho Young, additional, Kang, Sung Koo, additional, and Kang, Moo Il, additional
- Published
- 2006
- Full Text
- View/download PDF
156. A novel splice site mutation of the arginine vasopressin–neurophysin II gene identified in a kindred with autosomal dominant familial neurohypophyseal diabetes insipidus
- Author
-
Tae, Hyun-Jung, primary, Baek, Ki-Hyun, additional, Shim, Sun-Mi, additional, Yoo, Soon-Jib, additional, Kang, Moo-Il, additional, Cha, Bong-Yun, additional, Lee, Kwang-Woo, additional, Son, Ho-Young, additional, and Kang, Sung-Koo, additional
- Published
- 2005
- Full Text
- View/download PDF
157. A Novel IVS2-1G>A Mutation Causes Aberrant Splicing of theHRPT2Gene in a Family with Hyperparathyroidism-Jaw Tumor Syndrome
- Author
-
Moon, Sung-Dae, primary, Park, Jae-Hyun, additional, Kim, Eun-Min, additional, Kim, Ju-Hee, additional, Han, Je-Ho, additional, Yoo, Soon-Jib, additional, Yoon, Kun-Ho, additional, Kang, Moo-Il, additional, Lee, Kwang-Woo, additional, Son, Ho-Yong, additional, Kang, Sung-Koo, additional, Oh, Se-Jeong, additional, Kim, Kyung-Mi, additional, Yoon, Sung-Joo Kim, additional, Park, Jae-Gahb, additional, Kim, Il-Jin, additional, Kang, Hio Chung, additional, Hong, Soon-Won, additional, Kim, Kyung-Rae, additional, and Cha, Bong-Yun, additional
- Published
- 2005
- Full Text
- View/download PDF
158. Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system are associated with bone metabolism in middle-aged males
- Author
-
Oh, Ki Won, primary, Rhee, Eun Jung, additional, Lee, Won Young, additional, Kim, Sun Woo, additional, Baek, Ki Hyun, additional, Kang, Moo Il, additional, Yun, Eun Joo, additional, Park, Cheol Young, additional, Ihm, Sung Hee, additional, Choi, Moon Gi, additional, Yoo, Hyung Joon, additional, and Park, Sung Woo, additional
- Published
- 2005
- Full Text
- View/download PDF
159. The Effect of Simvastatin on the Proliferation and Differentiation of Human Bone Marrow Stromal Cells
- Author
-
Baek, Ki Hyun, primary, Lee, Won Young, additional, Oh, Ki Won, additional, Tae, Hyun Jung, additional, Lee, Jung Min, additional, Lee, En Jung, additional, Han, Je Ho, additional, Kang, Moo Il, additional, Cha, Bong Yun, additional, Lee, Kwang Woo, additional, Son, Ho Young, additional, and Kang, Sung Koo, additional
- Published
- 2005
- Full Text
- View/download PDF
160. Calcitropic Hormones and Systemic Factors of Vascular Calcification
- Author
-
Oh, Ki Won, primary and Kang, Moo Il, additional
- Published
- 2005
- Full Text
- View/download PDF
161. Official Positions of the International Society for Clinical Densitometry
- Author
-
Baek, Ki Hyun, primary and Kang, Moo-Il, additional
- Published
- 2005
- Full Text
- View/download PDF
162. The Effects of Osteoprotegerin Polymorphism on Bone Mineral Metabolism in Korean Women with Perimenopause
- Author
-
Oh, Ki Won, primary, Yun, Eun Joo, additional, Rhee, Eun Jung, additional, Lee, Won Young, additional, Baek, Ki Hyun, additional, Kang, Moo Il, additional, Park, Cheol Young, additional, Ihm, Sung Hee, additional, Choi, Moon Gi, additional, Yoo, Hyung Joon, additional, and Park, Sung Woo, additional
- Published
- 2005
- Full Text
- View/download PDF
163. The Changes in the Serum RANKL and OPG levels after Bone Marrow Transplantation: Association with Bone Mineral Metabolism
- Author
-
Tae, Hyun-Jung, primary, Baek, Ki-Hyun, additional, Oh, Eun-Sook, additional, Oh, Ki-Won, additional, Lee, Won-Young, additional, Kim, Hye-Soo, additional, Han, Je-Ho, additional, Cha, Bong-Yun, additional, Lee, Kwang-Woo, additional, Son, Ho-Young, additional, Kang, Sung-Koo, additional, Kim, Choon-Choo, additional, and Kang, Moo-Il, additional
- Published
- 2005
- Full Text
- View/download PDF
164. The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women
- Author
-
Oh, Ki Won, primary, Rhee, Eun Jung, additional, Lee, Won Young, additional, Kim, San Woo, additional, Oh, Eun Sook, additional, Baek, Ki Hyun, additional, Kang, Moo Il, additional, Choi, Moon Gi, additional, Yoo, Hyung Joon, additional, and Park, Sung Woo, additional
- Published
- 2004
- Full Text
- View/download PDF
165. The Skeletal Site-Differential Changes in Bone Mineral Density Following Bone Marrow Transplantation: 3-Year Prospective Study
- Author
-
Lee, Won Young, primary, Kang, Moo Il, additional, Baek, Ki Hyun, additional, Oh, Eun Sook, additional, Oh, Ki Won, additional, Lee, Kwang Woo, additional, Kim, Sun Woo, additional, and Kim, Choon Choo, additional
- Published
- 2002
- Full Text
- View/download PDF
166. Circulating IL-8 and IL-10 in Euthyroid Sick Syndromes following Bone Marrow Transplantation
- Author
-
Lee, Won Young, primary, Suh, Jung Yul, additional, Kim, Sun Woo, additional, Oh, Eun Sook, additional, Oh, Ki Won, additional, Baek, Ki Hyun, additional, Kang, Moo Il, additional, Lee, Kwang Woo, additional, and Kim, Choon Choo, additional
- Published
- 2002
- Full Text
- View/download PDF
167. Oncogenic osteomalacia associated with soft tissue chondromyxoid fibroma
- Author
-
Park, Jeong Mi, primary, Woo, Young Kyun, additional, Kang, Moo Il, additional, Kang, Chang Suk, additional, and Hahn, Seong Tae, additional
- Published
- 2001
- Full Text
- View/download PDF
168. The Effect of cilostazolon Glucose Tolerance and Insulin Resistance in a Rat Model of Non - insulin Dependent Diabetes Mellitus
- Author
-
Chang, Sang Ah, primary, Cha, Bong Yun, additional, Yoo, Soon Jib, additional, Ahn, Yo Bae, additional, Song, Ki Ho, additional, Han, Je Ho, additional, Lee, Jong Min, additional, Son, Hyun Sik, additional, Yoon, Kun Ho, additional, Kang, Moo Il, additional, Lee, Kwang Woo, additional, Son, Ho Young, additional, and Kang, Sung Ku, additional
- Published
- 2001
- Full Text
- View/download PDF
169. Hypodipsic hypernatremia with intact AVP response to non-osmotic stimuli induced by hypothalamic tumor: A case report
- Author
-
Kang, Mi Ja, primary, Yoon, Kun Ho, additional, Lee, Seong Su, additional, Lee, Jung Min, additional, Ahn, You Bae, additional, Chang, Sang Ah, additional, Kang, Moo Il, additional, Cha, Bong Yun, additional, Lee, Kwang Woo, additional, Son, Ho Young, additional, Kang, Sung Koo, additional, and Hong, Yong Kil, additional
- Published
- 2001
- Full Text
- View/download PDF
170. Quantification of the pancreatic beta-cell mass and insulin content in normal and type 2 diabetic subjects in Korea
- Author
-
Son, Ho-Young, primary, Yoon, Kun-Ho, additional, Ko, Seung-Hyun, additional, Seo, Sun-Hee, additional, Moon, Sung-Dae, additional, Chang, Sang-A, additional, Ahn, You-Bae, additional, Kang, Moo-Il, additional, Cha, Bong-Yun, additional, Lee, Kwang-Woo, additional, and Kang, Sung-Koo, additional
- Published
- 2000
- Full Text
- View/download PDF
171. Effects of cilostazol on insulin resistance in OLETF(ostuka long evans takushima fatty) rats
- Author
-
Cha, Bong-Yon, primary, Kim, Sung-rae, additional, Chang, Sang-ah, additional, Ahn, Yoo-bae, additional, Han, Je-ho, additional, Lee, Jong-min, additional, Son, Hyun-sik, additional, Yoon, Kun-ho, additional, Kang, Moo-il, additional, Lee, Kwang-woo, additional, Son, Ho-young, additional, and Kang, Sung-koo, additional
- Published
- 2000
- Full Text
- View/download PDF
172. Expression of multiple thyroid hormone receptor isoforms in rat femoral and vertebral bone and in bone marrow osteogenic cultures
- Author
-
Milne, Moira, primary, Kang, Moo-Il, additional, Cardona, Guemalli, additional, Quail, John M., additional, Braverman, Lewis E., additional, Chin, William W., additional, and Baran, Daniel T., additional
- Published
- 1999
- Full Text
- View/download PDF
173. Role of [18F]-Fluorodeoxy-D-Glucose Positron Emission Tomography and Computed Tomography in the Early Detection of Persistent/Recurrent Thyroid Carcinoma in Intermediate-to-High Risk Patients Following Initial Radioactive Iodine Ablation Therapy
- Author
-
Kim, Min-Hee, O, Joo Hyun, Ko, Sun Hee, Bae, Ja-Seong, Lim, Dong-Jun, Kim, Sung-Hoon, Baek, Ki-Hyun, Lee, Jong-Min, Kang, Moo-Il, Cha, Bong-Yun, and Lee, Kwang-Woo
- Subjects
THYROID cancer patients ,POSITRON emission tomography ,CATHETER ablation ,DISEASE risk factors ,ULTRASONIC imaging ,NUMERICAL calculations - Abstract
Background: Positron emission tomography/computed tomography (PET/CT) scan has a role in the surveillance of patients with a history of thyroid carcinoma. Its efficacy after remnant ablation as far as detecting persistent or recurrent thyroid carcinoma before other surveillance methods is not known, however. In intermediate-to-high risk thyroid carcinoma patients we studied whether PET/CT scan, performed 6-12 months after the first remnant ablation, could provide more information than ultrasonography (US) and thyrotropin-stimulated serum thyroglobulin (Tg) determination with diagnostic whole-body scan (DxWBS). Methods: We studied 71 subjects with differentiated thyroid cancer (DTC) who were intermediate-to-high risk for persistent/recurrent disease and who had received PET/CT scan, US, and DxWBS simultaneously with stimulated Tg levels 6-12 months after remnant ablation. To evaluate the diagnostic efficacy of PET/CT scan, the sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy were calculated. Results: Ten subjects (14%) had persistent/recurrent disease detected 6-12 months after remnant ablation. Persistence/recurrence was detected in nine (12.7%) of these patients by conventional methods, including US and DxWBS, along with stimulated Tg levels. The remaining case was detected solely by a PET/CT scan, which showed a mediastinal prevascular lesion; this was confirmed by a therapeutic WBS after additional radioiodine therapy. Among the six patients whose PET/CT scan showed positive results, five had persistent/recurrent disease. The sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of PET/CT scan for detecting persistent/recurrent thyroid carcinoma were 50%, 98.4%, 83.3%, 92.3%, and 91.5%, respectively. Conclusion: In intermediate-to-high risk patients with DTC seen 6-12 months after their first remnant ablation, there is almost no complementary role for adding a PET/CT scan to conventional follow-up methods, an US and a DxWBS simultaneously with stimulated Tg levels. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
174. The effects of C161 →T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-γ gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women.
- Author
-
Rhee, Eun-Jung, Oh, Ki-Won, Lee, Won-Young, Kim, Se-Yeon, Oh, Eun-Sook, Baek, Ki-Hyun, Kang, Moo-Il, and Kim, Sun-Woo
- Subjects
EXONS (Genetics) ,SPLIT genes ,PEROXISOMES ,GENETIC polymorphisms ,DISEASES in middle-aged women ,METABOLISM - Abstract
Objective: We evaluated the association of different genotypes in C161→T substitution in exon 6 of peroxisome proliferator-activated receptor-γ (PPARγ) gene with bone turnover markers, bone mineral density (BMD), and serum osteoprotegerin (OPG) in female subjects to reveal the role of PPARγ in bone. Study design: In 263 healthy Korean women (mean age 52 years), anthropometric measurements were taken along with measurements of lumbar spine and femoral neck BMD, bone turnover markers, such as alkaline phosphatase, serum calcium, phosphorus, 24-hour urine calcium, phosphorus excretion, and urine deoxypyridinoline. Serum follicular stimulating hormone levels were measured and serum OPG levels were measured with the enzyme-linked immunosorbent assay method. Polymerase chain reaction-restriction fragment length polymorphism was performed. Results: Allele frequencies were 0.804 for the C allele and 0.196 for the T allele. There were no differences in mean age, body mass index, BMD, and bone turnover markers among different genotypes, and the subjects with T alleles had significantly lower serum OPG levels. There were no differences in the prevalence of metabolic bone diseases according to the genotypes. When analyzed according to the menopausal status, only postmenopausal subjects with T alleles showed significantly lower serum OPG levels. Conclusion: The frequencies of C161→T substitution in exon 6 of the PPARγ gene in Korean females were similar to other races and women with T alleles showed significantly lower serum OPG levels and it was especially noted for postmenopausal subjects, which supports the possible concurrent association of PPARγ and OPG with estrogen status in female subjects. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
175. The association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor-? gene with serum osteoprotegerin levels in healthy Korean women
- Author
-
Rhee, Eun-Jung, Oh, Ki-Won, Yun, Eun-Joo, Jung, Chan-Hee, Park, Cheol-Young, Lee, Won-Young, Oh, Eun-Sook, Baek, Ki-Hyun, Kang, Moo-Il, Park, Sung-Woo, and Kim, Sun-Woo
- Abstract
Recent evidences suggest that the activation of peroxisome proliferator-activated receptor (PPAR)-?, which is an important transcriptional factor in adipocyte differentiation, also plays an important role in the bone microenvironment. The objective of the study was to clarify whether Pro12Ala polymorphism was related to the serum OPG levels and bone mineral metabolism in healthy Korean women. In 239 Korean women (mean age 51 years), who participated in medical check-up program in a health promotion center, anthropometric measurements, lumbar spine and femoral neck bone mineral density (BMD), bone turnover markers, such as serum total alkaline phosphatase (ALP) levels, urine deoxypyridinoline levels, and 24-h urine calcium excretion were measured. Serum levels of OPG were measured with ELISA method. DNAs were extracted from the samples and the genotyping of the Pro12Ala polymorphism (rs1801282) in the PPAR-? gene was performed via an allelic discrimination assay using a TaqMan probe. In addition, we examined the haplotype analysis between two polymorphisms of PPAR-? gene, Pro12Ala in exon B and C161T in exon 6 (rs3856806). Allelic frequencies were 0.950 for Pro allele and 0.050 for Ala allele, which was in compliance with Hardy- Weinberg equilibrium, and there was no Ala12Ala genotype among the genotyped subjects. Mean serum OPG level was significantly lower (P=0.035), and serum total ALP was significantly higher (P=0.014) in the Pro12Ala genotype group compared with the Pro12Pro genotype group, which were consistently significant even after adjustment for weight, height, and serum follicle stimulating hormone (FSH). In multiple regression analysis with serum OPG as the dependent variable and age, weight, ALP, femoral neck BMD and Pro12Ala genotype included in the model, only Pro12Ala genotype was significant determinant of serum OPG level (ß=-0.136, P=0.035). The haplotype analysis with C161T polymorphism revealed that subjects with Ala and T alleles showed significantly lower serum OPG levels compared with those with Pro12Pro/CC genotype, which were consistently significant even after adjustment for age, weight, height and FSH (P=0.010). This result suggests statistically significant association of Pro12Ala polymorphisms with serum OPG levels in Korean females.
- Published
- 2007
- Full Text
- View/download PDF
176. Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein
- Author
-
RHEE, Eun-Jung, LEE, Won-Young, KIM, Se-Yeon, KIM, Byung-Jin, SUNG, Ki-Chul, KIM, Bum-Su, KANG, Jin-Ho, OH, Ki-Won, OH, Eun-Sook, BAEK, Ki-Hyun, KANG, Moo-Il, WOO, Hee-Yeon, PARK, Hyo-Soon, KIM, Sun-Woo, LEE, Man-Ho, and PARK, Jung-Roe
- Abstract
OPG (osteoprotegerin) is an inhibitor of osteoclastogenesis and recent work suggests it has a role in atherosclerosis. Therefore we measured serum OPG levels in patients with coronary artery disease, compared the serum OPG levels among the different groups according to the number of stenotic vessels and determined whether there was any correlation with aortic calcification, LV (left ventricular) mass index and serum CRP (C-reactive protein) levels. Subjects (n=100; mean age, 57 years) who underwent coronary angiograms were enrolled. Blood pressure, body mass index, fasting blood glucose, lipid profiles and CRP levels were measured and the LV mass indices were calculated using ECGs. Serum OPG levels were measured by ELISA. The presence of calcification in the aortic notch was checked by a chest X-ray. The subjects were divided into four groups according to the number of stenotic vessels. The mean serum OPG levels increased significantly as the number of stenotic vessels increased, and the mean serum OPG levels were higher in the group with three-vessel disease compared with the groups with no- or one-vessel disease. The mean serum CRP level was significantly higher in the group with three-vessel disease compared with the groups with no-, one- and two-vessel disease. Age and LV mass index showed significant positive correlations with serum OPG levels, although significance was lost after an adjustment for age. Serum CRP levels were positively correlated with serum OPG levels even after an adjustment for age. There were no differences in serum OPG levels according to the presence of fasting hyperglycaemia or aortic calcification. In conclusion, serum OPG level was related to the severity of stenotic coronary arteries and serum CRP levels. LV mass indices showed no significant correlation with OPG levels. The precise mechanism for the role of OPG in atherosclerosis needs to be investigated further.
- Published
- 2005
- Full Text
- View/download PDF
177. Efficacy of risedronate with cholecalciferol on bone mineral density in Korean patients with osteoporosis.
- Author
-
Park, So Young, Kang, Moo-Il, Park, Hyung Moo, Rhee, Yumie, Moon, Seong Hwan, Yoon, Hyun Koo, Koh, Jung-Min, Chang, Jae Suk, Kim, In Joo, Won, Ye Yeon, Park, Ye Soo, Choi, Hoon, Shin, Chan Soo, Yoon, Taek Rim, Yun, Sung-Cheol, and Chung, Ho-Yeon
- Abstract
Summary: The efficacy of once-weekly risedronate with and without cholecalciferol in bone mineral density (BMD) in Korean patients with osteoporosis was compared. After 12 months, both spine and hip BMD increased significantly in both groups, but there was no significant difference between two groups. Introduction: This study investigated the efficacy and safety of once-weekly risedronate with and without cholecalciferol in BMD in Korean patients with osteoporosis. Methods: This was a prospective, 12-month, randomized, open-labeled, actively controlled trial involving 41 hospitals. A total of 841 subjects with osteoporosis were randomized to once-weekly risedronate (35 mg) and cholecalciferol (5600 IU) in a single pill (RSD+, n = 642) or once-weekly risedronate (35 mg) alone (RSD, n = 199). BMD was measured via dual-energy X-ray absorptiometry at the lumbar spine and hip, and the serum levels of 25-hydroxy vitamin D (25(OH) D), parathyroid hormone (PTH), and alkaline phosphatase (ALP) were assayed at baseline and after 12 months of treatment. Results: After 12 months, the lumbar spine, femoral neck, and total hip BMD increased significantly in both groups; there was no significant difference between two groups. Women in the RSD+ group exhibited significantly increased lumbar spine BMD, and subjects with previous fracture history in the RSD+ group had significantly increased total hip BMD compared with the RSD group. The serum 25(OH) D level increased significantly in the RSD+ group. The serum PTH level decreased in the RSD+ group but increased in the RSD group. The serum ALP level significantly decreased in both groups; there was no significant difference between two groups. Conclusions: A once-weekly pill containing risedronate and cholecalciferol had the equivalent antiresorptive efficacy on BMD compared with risedronate alone and improved 25(OH) D serum levels after 12 months of treatment without significant adverse events in Korean patients with osteoporosis. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
178. A Case of Normalized Hypertrophic Cardiomyopathy after Removal of Pheochromocytoma
- Author
-
Kang, Moo Il, primary, Oh, Chong Heung, additional, Chae, Jang Seong, additional, Kim, Jae Hyung, additional, Hong, Soon Jo, additional, Choi, Kyu Bo, additional, Kim, Hak Joong, additional, and Kim, Sun Moo, additional
- Published
- 1988
- Full Text
- View/download PDF
179. Comparison of Medical Student Responses and Course Achievement According to Different Types of Patient Simulations in an Introductory Advanced Life Support Course
- Author
-
Kim, Young-Min, primary, Lee, Won-Jae, additional, Kang, Moo-Il, additional, Kim, Sun, additional, Park, Joo-Hyun, additional, and Park, Ji-Eun, additional
- Published
- 1970
- Full Text
- View/download PDF
180. Calcification Patterns in Papillary Thyroid Carcinoma are Associated with Changes in Thyroid Hormones and Coronary Artery Calcification.
- Author
-
Ha, Jeonghoon, Lee, Jeongmin, Jo, Kwanhoon, Han, Jeong-Sun, Kim, Min-Hee, Jung, Chan Kwon, Kang, Moo IL, Cha, Bong Yeon, and Lim, Dong-Jun
- Subjects
CALCIFICATION ,CARCINOMA ,THYROID hormones ,CORONARY artery abnormalities ,ULTRASONIC imaging ,THERAPEUTICS - Abstract
Recent studies suggested that a lower serum thyroid hormone level is associated with more vascular calcification. However, it has been rarely evaluated whether lower thyroid hormone levels affect the calcification of thyroid cancer and there is a relationship between calcification patterns of papillary thyroid carcinoma (PTC) and coronary artery calcification (CAC). The study was divided into two groups: First, we retrospectively reviewed 182 PTC patients and examined the correlation between PTC calcification patterns and CAC by coronary computed tomography (CT). Second, the correlation between the calcification pattern of PTC and thyroid hormone concentration was investigated (
n = 354). The calcification pattern of PTC was evaluated by thyroid ultrasonography and classified into four groups: no-calcification, microcalcification, macrocalcification, and mixed-calcification. In PTC patients with microcalcification and mixed calcification, more CAC was observed and coronary calcium score (CCS) was higher. Lower free T4 and higher thyroid-stimulating hormone (TSH) levels were associated with microcalcification and mixed calcification, not with macrocalcification and no calcification. PTC with microcalcification and mixed calcification showed more aggressive phenotypes like lymph node metastasis and more advanced TNM (tumor, node, and metastasis) stage than those with no calcification and macrocalcification. Calcification patterns of PTC showed close association with thyroid hormone levels and CAC. Further research is needed to determine how these findings are related to cardiovascular risk and disease-specific mortality. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
181. Prognostic value of preoperative anti-thyroglobulin antibody in differentiated thyroid cancer.
- Author
-
Jo, Kwanhoon, Kim, Min‐Hee, Ha, Jeonghoon, Lim, Yejee, Lee, Sohee, Bae, Ja Seong, Jung, Chan Kwon, Kang, Moo Il, Cha, Bong Yun, and Lim, Dong‐Jun
- Subjects
- *
THYROID cancer , *THYROGLOBULIN , *ANTI-antibodies , *AUTOIMMUNE diseases , *PREOPERATIVE period , *THYROIDECTOMY , *PROGNOSIS - Abstract
Context The coexistence of differentiated thyroid cancer ( DTC) and thyroid autoimmune disease could represent a better or worse prognosis. This study investigated the prognostic importance of preoperative anti-thyroglobulin antibody (TgAb) in DTC patients. Design and patients This retrospective hospital-cohort study enrolled 1171 consecutive DTC patients with preoperative TgAb data, who underwent total thyroidectomy between January 2006 and December 2011. Clinical parameters studied included demographics, primary tumour characteristics, radioiodine therapy, thyroid function tests, preoperative thyroglobulin (Tg) and TgAb levels, and cancer persistence/recurrence. Results A total of 254 (21.7%) patients were preoperatively TgAb positive. The percentage positive for thyroid peroxidase ( TPO) antibody and lymphocytic thyroiditis was significantly higher in the TgAb-positive group. The TgAb-positive group had a significantly higher rate of lymphatic invasion and lymph node metastasis both overall and in patients without TPOAb and lymphocytic thyroiditis (non- HT group). The mean number of total and central lymph nodes dissected and rate of lateral lymph node dissection were significantly higher in the TgAb-positive group, both overall and in non- HT patients. In regression analysis, preoperative TgAb was an independent risk factor for lateral lymph node metastasis. Over 50.2±14.5 months of follow-up, disease persistence/recurrence was not significantly different between patients with and without TgAb, both overall and in non- HT patients. Preoperative TgAb showed no significant correlation with final disease status. Conclusion Positive preoperative serum TgAb is associated with worse primary tumour characteristics but rarely showed poor prognosis, probably due to more aggressive treatment of these subjects. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
182. Decreased Plasma Levels of Sclerostin But Not Dickkopf-1 are Associated with an Increased Prevalence of Osteoporotic Fracture and Lower Bone Mineral Density in Postmenopausal Korean Women.
- Author
-
Lim, Yejee, Kim, Chong, Lee, Sun-Young, Kim, Hyeonmok, Ahn, Seong, Lee, Seung, Koh, Jung-Min, Rhee, Yumie, Baek, Ki, Min, Yong-Ki, Kim, Deog-Yoon, Kim, Beom-Jun, Kang, Moo-Il, Kim, Chong Hwa, Ahn, Seong Hee, Lee, Seung Hun, and Baek, Ki Hyun
- Subjects
- *
OSTEOPOROSIS in women , *POSTMENOPAUSE , *BONE density , *BLOOD plasma , *SCLEROSTIN , *DISEASE prevalence , *KOREANS , *BONE metabolism , *DISEASES , *ASIANS , *BONE morphogenetic proteins , *GENES , *GROWTH factors , *MULTIVARIATE analysis , *OSTEOPOROSIS , *GENETIC markers , *BODY mass index , *CASE-control method , *ODDS ratio ,RESEARCH evaluation - Abstract
Although sclerostin (SOST) and Dickkopf-related protein 1 (DKK1) are major regulators in bone metabolism, their associations with osteoporotic fracture (OF) in Asians are inconclusive. Furthermore, there have been no clinical studies separately considering non-vertebral and vertebral fractures in terms of the blood levels of SOST and DKK1. Among 513 consecutive postmenopausal Korean women, we identified 103 cases defined as subjects with OF (i.e., non-vertebral and/or vertebral fractures). The controls were randomly selected from the remaining 410 subjects and matched 1:1 to cases according to both age and body mass index. Non-vertebral and morphological vertebral fractures were identified by an interviewer-assisted questionnaire and lateral thoracolumbar radiographs, respectively. Bone mineral density (BMD) and plasma levels of SOST and DKK1 were measured. Plasma SOST levels were lower in subjects with OF than in the control group. Each standard deviation decrement of plasma SOST concentration was associated with a multivariable-adjusted odds ratio of 1.77 for any prevalent OF type. The odds for OF was 2.97-fold higher in subjects in the lowest SOST tertile compared with subjects in the highest SOST tertile. These associations remained significant when the non-vertebral and vertebral fractures were analyzed separately. However, prevalent OF was not associated with plasma DKK1 levels, regardless of the type of fracture and the adjustment model employed. Consistently, plasma SOST levels were positively related with BMD values at all measured skeletal sites, although this was not observed for DKK1. Circulating SOST but not DKK1 may be a potential biomarker for predicting bone health in Asians. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
183. Gender- and age-group-specific associations between physical performance and bone mineral density, falls, and osteoporotic fractures in Koreans: the Chungju Metabolic Disease Cohort study.
- Author
-
Lim, Yejee, Kim, Kyunghee, Ko, Sun-Hee, Cho, Kwanhoon, Jang, Eun-Hee, Lee, Seung-Hwan, Lim, Dong, Baek, Ki, Ha, Hee-Sung, Park, Mi, Yim, Hyeon-Woo, Lee, Won-Chul, Yoon, Kun-Ho, Son, Ho, Oh, Ki, Kang, Moo-Il, Lim, Dong Jun, Baek, Ki Hyun, Park, Mi Sun, and Son, Ho Young
- Subjects
- *
BONE density , *OSTEOPOROSIS , *BONE fractures , *ACCIDENTAL falls , *BONE diseases - Abstract
Several factors increase the risk of fragility fracture, including low bone mineral density, falls, and poor physical performance. The associations among these factors have been investigated; however, most of the subjects of previous studies were either elderly men or elderly women, and the associations were controversial. The aim of this study was to evaluate the associations between physical performance and bone mineral density, and the history of falls and fractures, stratified by gender and age group. We analyzed 5368 subjects who were aged 50 years or older, including 1288 younger men (younger than 70 years), 1615 younger women (younger than 70 years), 1087 older men (70 years or older), and 1378 older women (70 years or older). We used the one-leg standing time (OLST) for assessing static balance and the timed up-and-go test (TUGT) for assessing dynamic balance. The subjects in the worst performance quartile for the OLST were more likely to have osteoporosis than those in the best performance quartile. Additionally, women who had experienced a fracture during the past 2 years were 1.68 times more likely to be in the worst performance quartile for the OLST than women without a previous fracture. Although the TUGT time was not associated with either the incidence of osteoporosis or the fracture history, the odds ratios for falling were 1.51 and 1.28 as the TUGT time increased by one standard deviation in younger men and younger women, respectively. The findings of the present study show that the OLST was associated with the incidence of osteoporosis and previous fracture and that the TUGT time was associated with the incidence of falling. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
184. Plasma periostin associates significantly with non-vertebral but not vertebral fractures in postmenopausal women: Clinical evidence for the different effects of periostin depending on the skeletal site.
- Author
-
Kim, Beom-Jun, Rhee, Yumie, Kim, Chong Hwa, Baek, Ki Hyun, Min, Yong-Ki, Kim, Deog-Yoon, Ahn, Seong Hee, Kim, Hyeonmok, Lee, Seung Hun, Lee, Sun-Young, Kang, Moo-Il, and Koh, Jung-Min
- Subjects
- *
PERIOSTIN , *CELL adhesion molecules , *BONE injuries , *MUSCULOSKELETAL system , *BONE fractures - Abstract
Background Periostin is preferentially expressed by the periosteum, which mainly covers the long bones. Therefore, the role of periostin in osteoporotic fracture (OF) may differ depending on bone type. We performed a case–control study to investigate whether periostin can serve as a predictor of OF risk, particularly after dividing OFs into non-vertebral and vertebral fractures. Methods Among 532 consecutive postmenopausal women not taking any drug or without any disease that could affect bone metabolism, 133 cases with OF ( i.e. , non-vertebral and/or vertebral fractures) and 133 age- and body mass index-matched controls were enrolled. Non-vertebral ( i.e. , forearm, humerus, hip, and pelvis; n = 81) and morphological vertebral (n = 62) fractures were identified by an interviewer-assisted questionnaire and lateral thoracolumbar radiographs, respectively. Bone mineral density (BMD) and plasma periostin levels were also measured. Results Plasma periostin was markedly higher in subjects with non-vertebral fracture than their controls even after adjustment for BMD and potential confounders ( P = 0.006). Each standard deviation increment of plasma periostin was associated with a multivariable-adjusted odds ratio of 1.59 for non-vertebral fracture. The odds for non-vertebral fracture were 2.48-fold higher in subjects in the highest periostin tertile compared with those in the lowest periostin tertile (95% confidence interval = 1.10–5.61). However, associations between plasma periostin and vertebral fracture were not observed, regardless of the adjustment model used. Consistently, plasma periostin levels were inversely associated with proximal femur BMD ( P = 0.007 to 0.030) but not lumbar spine BMD. In subgroup analyses, plasma periostin had no correlation with the levels of classical bone turnover markers. Conclusions Plasma periostin may be a potential biomarker of the risk of OF, especially in non-spinal skeletal sites, such as the limbs, rather than spine. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
185. The effects of thyrotropin-suppressing therapy on bone metabolism in patients with well-differentiated thyroid carcinoma.
- Author
-
Kim, Mee Kyoung, Yun, Kyung-Jin, Kim, Min-Hee, Lim, Dong-Jun, Kwon, Hyuk-Sang, Song, Ki-Ho, Kang, Moo-Il, and Baek, Ki Hyun
- Subjects
- *
THYROTROPIN , *IMMUNOSUPPRESSION , *BONE metabolism , *THYROID cancer patients , *LEVOTHYROXINE , *DISEASE risk factors , *OSTEOPOROSIS , *DUAL-energy X-ray absorptiometry - Abstract
Studies on the effects of levothyroxine (LT4) therapy on bone and bone metabolism have yielded conflicting results. This 1-year prospective study examined whether LT4 in patients with well-differentiated thyroid carcinoma (DTC) is a risk factor for bone mass loss and the subsequent development of osteoporosis. We examined 93 patients with DTC over 12 months after initiating LT4 therapy (early postoperative period). We examined another 33 patients on long-term LT4 therapy for DTC (late postoperative period). Dual energy X-ray absorptiometry was performed at baseline and after 1 year. The mean bone losses during the early postoperative period in the lumbar spine, femoral neck, and total hip, calculated as the percentage change between levels at baseline and 12 months, were − 0.88, − 1.3 and − 0.81%, respectively. Bone loss was more evident in postmenopausal women (lumbar spine − 2.1%, femoral neck − 2.2%, and hip − 2.1%; all P < 0.05). We compared the changes in annual bone mineral density (BMD) in postmenopausal women according to calcium/vitamin D supplementation. Bone loss tended to be higher in the postmenopausal women receiving no supplementation. There was no decrease in BMD among patients during the late postoperative period. The mean bone loss was generally greater in the early than in the late postoperative group, and this was significant at the lumbar spine ( P = 0.041) and femoral neck ( P = 0.010). TSH-suppressive levothyroxine therapy accelerates bone loss, predominantly in postmenopausal women and exclusively during the early post-thyroidectomy period. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
186. Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness.
- Author
-
Shin, Jeong‐Ah, Lee, Jin‐Hee, Lim, Sun‐Young, Ha, Hee‐Sung, Kwon, Hyuk‐Sang, Park, Yong‐Moon, Lee, Won‐Chul, Kang, Moo‐Il, Yim, Hyeon‐Woo, Yoon, Kun‐Ho, and Son, Ho‐Young
- Subjects
- *
METABOLIC syndrome , *TYPE 2 diabetes , *DISEASE risk factors , *GLUCOSE intolerance , *CARDIOVASCULAR diseases - Abstract
Metabolic syndrome is defined as a cluster of glucose intolerance, hypertension, dyslipidemia and central obesity with insulin resistance as the source of pathogenesis. Although several different combinations of criteria have been used to define metabolic syndrome, a recently published consensus recommends the use of ethnic-specific criteria, including waist circumference as an indicator of central obesity, triglyceride and high-density lipoprotein ( HDL) cholesterol as indicators of dyslipidemia, and blood pressure greater than 130/85 mmHg. The definition of dysglycemia, and whether central obesity and insulin resistance are essential components remain controversial. Regardless of the definition, the prevalence of metabolic syndrome is increasing in Western and Asian countries, particularly in developing areas undergoing rapid socioenvironmental changes. Numerous clinical trials have shown that metabolic syndrome is an important risk factor for cardiovascular disease ( CVD), type 2 diabetes mellitus and all-cause mortality. Therefore, metabolic syndrome might be useful as a practical tool to predict these two major metabolic disorders. Comprehensive management of risk factors is very important to the improvement of personal and public health. However, recent studies have focused on the role metabolic syndrome plays as a risk factor for CVD; its importance in the prediction of incident diabetes is frequently overlooked. In the present review, we summarize the known evidence supporting metabolic syndrome as a predictor for type 2 diabetes mellitus and CVD. Additionally, we suggest how metabolic syndrome might be useful in clinical practice, especially for the prediction of diabetes. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
187. Endocrinopathies in transfusion-associated iron overload.
- Author
-
Kim, Mee Kyoung, Lee, Jong Wook, Baek, Ki Hyun, Song, Ki Ho, Kwon, Hyuk Sang, Oh, Ki Won, Jang, Eun Hee, Kang, Moo Il, and Lee, Kwang Woo
- Subjects
- *
APLASTIC anemia , *HEMOCHROMATOSIS , *ENDOCRINE function tests , *BLOOD transfusion , *IRON in the body , *GLUCOSE tolerance tests - Abstract
Background Transfusional iron overload primarily results in reticuloendothelial iron accumulation, which is considered to be less harmful than parenchymal iron accumulation. However, systematic and comprehensive data on endocrine function in transfusion-associated haemochromatosis are limited. Methods We examined 25 aplastic anaemia patients (11 men and 14 women) diagnosed with transfusion-associated haemochromatosis at a single institution. Pituitary function was determined with a combined pituitary function test. On a different day, a 75-g oral glucose tolerance test was performed. The bone mineral density ( BMD) of the lumbar spine and total hip was assessed with dual-energy X-ray absorptiometry. Results Twenty-two (88%) of these 25 patients had at least one endocrine abnormality, and 12 had more than one abnormality. The most common pituitary hormonal deficiency involved the pituitary-gonadal axis; 54% of the total subjects had hypogonadotropic hypogonadism. Two patients had an insufficient cortisol response to corticotrophin-releasing hormone stimulation. No patient had a deficiency of growth hormone or thyroid-stimulating hormone. Twelve (48%) had diabetes mellitus, and these patients tended to have higher concentrations of ferritin, alanine aminotransferase and γ-glutamyl transferase. Osteoporosis ( T-score <−2·5 SD) was observed in 48% of patients. The reduction in BMD was more pronounced in the lumbar spine than in the total hip. The patients with osteoporosis were accompanied by hypogonadism, which predominantly affected the trabecular bone. Conclusions Our observations suggest that endocrinopathies are common in transfusion-associated haemochromatosis. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
188. Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitus
- Author
-
Kim, Eun Sook, Kwon, Hyuk Sang, Ahn, Chul Woo, Lim, Dong Jun, Shin, Jeong Ah, Lee, Seung Hwan, Cho, Jae Hyoung, Yoon, Kun Ho, Kang, Moo Il, Cha, Bong Yun, and Son, Ho Young
- Subjects
- *
URIC acid , *ALBUMINURIA , *METABOLIC syndrome , *SERUM , *TYPE 2 diabetes , *PEOPLE with diabetes , *URINALYSIS , *ANTHROPOMETRY , *KOREANS , *DISEASES - Abstract
Abstract: Aims: To determine the relationship between serum uric acid, metabolic syndrome (MetS), and albuminuria in type 2 diabetic patients. Methods: A total of 504 Korean patients with type 2 diabetes aged 57.3 years were retrospectively evaluated for clinical histories, anthropometric measurements, and biochemical studies. Urinary albumin excretion (UAE) was measured by a 24-h urine collection. Results: Prevalence of MetS increased according to the quartiles of uric acid levels (≤3.7, 3.8 to 4.5, 4.6 to 5.5, and >5.5 mg/dl; 52.1%, 52.1%, 57.5%, and 71.6%, respectively, P<.001). Individual components of MetS (abdominal obesity, hypertriglyceridemia, low HDL-cholesterol, high blood pressure) were also significantly associated with the highest quintile of uric acid levels. Serum uric acid levels had significantly increased risk of albuminuria [odds ratio (OR) 1.425, 95% confidence interval (CI) 1.085-1.873] after adjusting for age, gender, and conventional risk factors. Uric acid level remains a significant predictor for abnormal albuminuria after adjusting for MetS presence as well as the use of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB) (OR 1.414, 95% CI 1.071-1.868). Conclusion: An elevated uric acid level was significantly associated with MetS and was an independent predictor of albuminuria after adjusting for conventional risk factors and MetS. Regular measurements of uric acid level could give information for predicting the presence of MetS and albuminuria in Korean type 2 diabetic patients. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
189. Erythropoietin response to anemia and its association with autonomic neuropathy in type 2 diabetic patients without advanced renal failure
- Author
-
Kim, Mee Kyoung, Baek, Ki Hyun, Lim, Dong Jun, Kim, Young Kyu, Kang, Moo-Il, Lee, Kwang-Woo, and Song, Ki-Ho
- Subjects
- *
ERYTHROPOIETIN , *PEOPLE with diabetes , *ACUTE kidney failure , *NEUROPATHY , *CROSS-sectional method , *HEMOGLOBINS , *DIAGNOSIS - Abstract
Abstract: Aim: We aim to investigate erythropoietin (EPO) response to anemia and its association with autonomic neuropathy in type 2 diabetic patients without advanced renal failure. Methods: A cross-sectional study was conducted on 211 type 2 diabetes mellitus patients without advanced renal failure [estimated glomerular filtration rate (eGFR) >40 ml/min/1.73 m2]. The response of EPO to anemia of type 2 diabetic patients without advanced renal failure was compared with those of nondiabetic control subjects. Autonomic nerve function was assessed using three cardiovascular tests (deep breathing, the Valsalva maneuver, and lying-to-standing). The results of each test were scored as 0 if normal, 1 if borderline, and 2 if abnormal. Autonomic neuropathy was diagnosed when a total score of the tests was 2 or more. Results: Fifty-eight patients were anemic; compared with nonanemic patients, they had a longer duration of diabetes (16.69±10.11 vs. 10.67±8.41 years, P<.001), lower eGFR (66.43±16.30 vs. 81.74±19.49 ml/min/1.73 m2, P<.001), and higher cardiovascular autonomic neuropathy score (3.17±1.95 vs. 1.79±1.72, P<.001). Serum EPO level was weakly correlated with hemoglobin (Hb) level (r=−.085, P<.001). However, the slopes of regression lines between EPO and Hb levels differed significantly between type 2 diabetic patients and nondiabetic control subjects (−0.0085 vs. −0.255, P=.008). Multiple linear regression analysis revealed that cardiovascular autonomic neuropathy score was independently related to Hb (P<.001) or EPO level (P=.052). Conclusions: Autonomic neuropathy is associated with a blunted EPO response to anemia in type 2 diabetic patients without advanced renal failure. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
190. Short-term changes in bone and mineral metabolism following gastrectomy in gastric cancer patients
- Author
-
Baek, Ki Hyun, Jeon, Hae Myung, Lee, Seong Su, Lim, Dong Jun, Oh, Ki Won, Lee, Won Young, Rhee, Eun Jung, Han, Je Ho, Cha, Bong Yun, Lee, Kwang Woo, Son, Ho Young, Kang, Sung Koo, and Kang, Moo Il
- Subjects
- *
BONES , *PUBLIC health , *METABOLISM , *GASTRECTOMY , *CANCER patients - Abstract
Abstract: Changes in bone and mineral metabolism that occur after gastrectomy have long been recognized. Gastrectomy has been identified as a risk factor for decreased bone mass and the increased fracture incidence. Previous investigations concerning postgastrectomy bone disease have been observational studies. No prospective studies have been reported that quantify the amount of bone loss after gastrectomy within the same patients. This study investigated 46 patients undergoing gastrectomy for gastric adenocarcinoma and analyzed 36 patients (58.1±10.8 years, 24 men and 12 women) who had dual energy X-ray absorptiometry (DXA) performed before and 1 year after gastrectomy. Systemic adjuvant chemotherapy was administered to 14 patients. Blood was sampled from all patients to determine serum calcium, phosphorous, and bone turnover marker levels before gastrectomy and at 1, 3, 6 and 12 months after surgery and for serum parathyroid hormone (PTH) and 25-hydroxyvitamin D levels before and 12 months after surgery. The mean bone loss in the lumbar spine, total hip, femoral neck, and trochanter, which was calculated as the percentage change from the baseline to the level measured at 12 months, was 5.7% (P <0.01), 5.4% (P <0.01), 6.6% (P <0.01) and 8.7% (P <0.01), respectively. Bone loss was generally greater in the group receiving chemotherapy. The serum calcium and phosphorous levels were not changed significantly and remained within the normal range throughout the observation period. After gastrectomy, the level of ICTP increased and reached a peak at 1 and 3 months, and progressively declined to baseline by 12 months. The osteocalcin levels were not coupled to an increase before 6 months. The level of 25-hydroxyvitamin D at 12 months postgastrectomy was not significantly changed compared to the baseline, however, the PTH levels increased by a mean of 63.6% at 12 months compared to the baseline (P <0.01). Significant correlations were found between the percent change in the BMD at the lumbar spine and total hip and the percentage change for the PTH level from their baselines to 12 months. The changes in the BMD at total hip, femoral neck, and trochanter also correlated to the change in body weight at 12 months. The data obtained by this study provides evidence that profound bone loss occurs in the setting of a bone remodeling imbalance during the early postgastrectomy period and allows the speculation that the gastrectomy related bone loss may be partially due to an overproduction of PTH. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
191. Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: Influences on bone and mineral metabolism
- Author
-
Baek, Ki Hyun, Oh, Ki Won, Lee, Won Young, Tae, Hyun Jung, Rhee, Eun Jung, Han, Je Ho, Cha, Bong Yun, Kim, Yoo Jin, Lee, Kwang Woo, Son, Ho Young, Kang, Sung Koo, Kim, Chun Choo, and Kang, Moo Il
- Subjects
- *
SERUM , *BONE marrow transplantation , *STEROIDS , *LIGANDS (Biochemistry) , *CYTOKINES - Abstract
Abstract: This study prospectively investigated the changes of the serum levels of the sex steroids, IL-7, soluble receptor activator of nuclear factor κB ligand (sRANKL) and osteoprotegerin (OPG) in bone marrow transplantation (BMT) recipients. This study also examined whether the changes of these cytokine levels and sex steroids actually influence bone turnover and post-BMT bone loss by correlation analysis. Data were analyzed from 39 patients (33.6±6.4 years, 19 men and 20 women) who had DXA performed before BMT and at 1 year after BMT. The bone turnover markers, sex steroids and the cytokine levels were measured before BMT and serially after BMT. The mean bone loss in the lumbar spine and the total proximal femur was 5.9% (P <0.01) and 11.3% (P <0.01), respectively. During the immediate post-BMT period, bone formation decreased, whereas the bone resorption increased. For the female recipients, the estradiol levels declined at 1 week after BMT, and they did not recover to the basal levels. For the male recipients, the testosterone levels decreased at 1 week and then it increased to its baseline level. The IL-7 levels reached their maximum at 1 week and then declined to baseline level by 3 months. The serum sRANKL, OPG levels and the sRANKL/OPG ratio showed their peak at post-BMT 3 weeks. The mean daily dose of steroid was associated with suppressed bone formation, enhanced bone resorption and increased sRANKL levels. The IL-7 levels were also noted to be either positively correlated with the levels of ICTP or they were negatively correlated with the levels of osteocalcin at 1 and 3 weeks after BMT. Bone loss at the lumbar spine and the proximal femur was influenced by the decreased sex steroids and increased IL-7 levels. During the observation period, the IL-7 levels showed positive correlations with the sRANKL levels and the sRANKL/OPG ratio. For the female patients, the serum IL-7 levels were negatively associated with the estradiol levels at 1 and 3 weeks after BMT. All these findings suggest that IL-7 plays an important role for post-BMT bone loss, and this possibly happens via the RANKL pathway. These data also suggest that the up-regulation of IL-7 during the early post-BMT period may result from a deficiency of estrogen. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
192. Measures of physical performance as a predictor of fracture risk independent of BMD: The Chungju metabolic disease cohort study.
- Author
-
Lim, Yejee, Ha, Jeonghoon, Yoon, Kun Ho, Baek, Ki Hyun, and Kang, Moo-Il
- Subjects
- *
PHYSICAL mobility , *METABOLIC disorders , *BONE density , *COHORT analysis , *FEMUR neck - Abstract
Bone mineral density (BMD) assessments alone might not be sufficient for assessing fracture risk in the whole population, and decreased balance is an important risk factor for fracture. The aim of this study was to evaluate the association between baseline physical performance and fracture risk. This community-based cohort study was conducted in rural areas. The follow-up examination was performed in 4015 subjects for approximately 4 years. We used the one-leg standing time (OLST) to assess static balance and the timed up-and-go test (TUGT) to assess dynamic balance. Fractures were assessed during the medical interview. The participants were divided into quartile groups according to their performance level, and the lowest baseline OLST performance was associated with a 2.1-fold increased risk of major osteoporotic fracture (MOF) independent of age, gender, hip BMD, fall incidence, and lifestyle factors. The participants in the low performance quartile of baseline OLST or TUGT performance had an increased incidence of osteoporosis and falling compared to that in the participants in the highest baseline performance quartile after adjusting for covariates. Among the participants with a femoral neck T-score above −2.5, the participants with an OLST below 14 s had a 1.7-fold higher risk of MOF than the participants with an OLST of 14 s or more. The measurement of static balance by the OLST predicted the risk of fracture in Korean adults independent of BMD and fall history. Our results suggest that the OLST may have clinical utility in identifying individuals at risk of fracture, especially those who might not be adequately identified by BMD measurements alone. • Low one-leg standing time (OLST) was associated with higher fracture risk. • Low OLST resulted in higher incidence of falls and osteoporosis. • An OLST under 14 s resulted in high fracture risk despite T-score above −2.5. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
193. Serum CYFRA 21.1 Level Predicts Disease Course in Thyroid Cancer with Distant Metastasis.
- Author
-
Jeong, Chaiho, Lee, Jeongmin, Yoon, Hyukjin, Ha, Jeonghoon, Kim, Min-Hee, Bae, Ja-Seong, Jung, Chan-Kwon, Kim, Jeong-Soo, Kang, Moo-Il, Lim, Dong-Jun, and Troncone, Giancarlo
- Subjects
- *
THYROID gland tumors , *METASTASIS , *CANCER patients - Abstract
Simple Summary: The role of serum Cyfra 21.1 as a biomarker in thyroid cancer has yet to be validated. This study investigated the diagnostic or prognostic role of serum Cyfra 21.1 in thyroid cancer. In the present analysis, we found that serum Cyfra 21.1 was increased in thyroid cancer with distant metastasis compared with thyroid cancer without metastasis. Furthermore, in progressive disease when thyroglobulin was undetectable or thyroglobulin monitoring was useless because of thyroglobulin antibody, serial follow-up based on serum Cyfra 21.1 levels might be used as an alternative biomarker for disease monitoring. Background: Serum Cyfra 21.1, the soluble fragment of CK19, has been used as a prognostic tumor marker in various cancers, indicating poor tumor differentiation and increased metastasis. Methods: We analyzed the serum Cyfra 21.1 level in 51 consecutive patients with thyroid cancer manifesting distant metastasis treated with prior total thyroidectomy. Serum Cyfra 21.1 levels of 26 thyroid cancer patients without metastasis and 50 healthy individuals were used for comparison. Results: Higher serum Cyfra 21.1 levels were detected in thyroid cancer patients with distant metastasis compared with healthy subjects and thyroid cancer patients without metastasis (p = 0.012). Serum Cyfra 21.1 levels were significantly increased in patients with positive BRAF V600E mutation (p = 0.019), undergoing Tyrosine Kinase Inhibitor (TKI) therapy (p = 0.008), with radioiodine-refractory status (p = 0.047), and in disease progression compared with those manifesting stable disease (p = 0.007). In progressive disease with undetectable or unmonitored thyroglobulin because of thyroglobulin antibody, serum Cyfra 21.1 was useful as a biomarker for follow-up of disease course. Conclusion: Serum Cyfra 21.1 in thyroid cancer patients might represent an alternative biomarker predicting tumor progression, especially in cases not associated with serum Tg levels. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
194. Effect of bisphosphonate on the prevention of bone loss in patients with gastric cancer after gastrectomy: A randomized controlled trial.
- Author
-
Ha, Jeonghoon, Lee, Jung-Min, Lim, Yejee, Kim, Mee Kyoung, Kwon, Hyuk-Sang, Song, Ki-Ho, Jeon, Hae Myung, Kang, Moo Il, and Baek, Ki-Hyun
- Subjects
- *
FEMUR neck , *STOMACH cancer , *BONE density , *RANDOMIZED controlled trials , *LUMBAR vertebrae - Abstract
Bone loss is highly prevalent after gastrectomy in gastric cancer patients. Therefore, the efficacy of medical treatment should be evaluated in patients undergoing gastrectomy. We conducted an unblinded, randomized controlled trial of patients who underwent gastrectomy to treat gastric cancer. The intention-to-treat participants (n = 107) were randomly assigned to receive either alendronate at a weekly dose of 70 mg and daily elemental calcium (500 mg) with cholecalciferol (1000 IU) or daily elemental calcium (500 mg) with cholecalciferol (1000 IU) only. The primary endpoint was defined by the changes in bone mineral density of four measurement sites: the lumbar spine, femur neck, total hip, and trochanter. Changes in bone turnover markers, osteocalcin and collagen I carboxyterminal telopeptide were also observed. At baseline, there were no differences between the two groups in bone mineral density. In the lumbar spine and trochanter, there were no significant percentage changes compared with the baseline in the alendronate group, but a significant decrease was noted in the control group (p < 0.001 for both lumbar spine and trochanter). In the femur neck and total hip, a larger decrease was observed compared with the baseline in the control group (p < 0.001 for both femur neck and total hip). Significant percentage increases in serum osteocalcin compared with baseline were noted in the control group (p for trend <0.001), but there was no change in the alendronate group (p for trend = 0.713). Collagen I carboxyterminal telopeptide significantly declined in the alendronate group over 12 months (p for trend <0.001). Prevention and treatment with bisphosphonate effectively reduces bone loss by suppressing bone resorption in gastric cancer patients undergoing gastrectomy. • Bone loss is highly prevalent after gastrectomy in gastric cancer patients. • The efficacy and safety of bisphosphonate was evaluated in patients who underwent gastrectomy by an unblinded, randomized controlled trial. • In the alendronate group, bone mineral density decreased in femoral neck and total hip, but less compared to the control group. • Bisphosphonate effectively reduces bone loss in gastric cancer patients undergoing gastrectomy. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
195. Association between Sleep Duration and Subclinical Thyroid Dysfunction Based on Nationally Representative Data.
- Author
-
Kim, Woojun, Lee, Jeongmin, Ha, Jeonghoon, Jo, Kwanhoon, Lim, Dong-Jun, Lee, Jung-Min, Chang, Sang-Ah, Kang, Moo-Il, and Kim, Min-Hee
- Subjects
- *
CHRONOBIOLOGY disorders , *MULTIPLE regression analysis , *SLEEP , *THYROID diseases - Abstract
Background: Sleep duration is an identified risk factor for adverse health outcomes. As the endocrine system is closely intertwined with sleep duration and quality, the association between endocrine dysfunction and sleep has been evaluated. Thyroid function, particularly that related to thyrotropin (TSH), is also known to be influenced by the sleep/awake status and circadian rhythm. Additionally, a link between sleep duration and autoimmunity, which is a common cause of thyroid dysfunction, has been suggested; however, depending on the sleep deprivation method used in studies, the effects of sleep on thyroid function vary. The relationship between subclinical thyroid dysfunction and sleep duration is poorly documented. Thus, to elucidate the impact of sleep on thyroid function, we investigated the association of subclinical thyroid dysfunction with sleep duration using representative data from the sixth Korea National Health and Nutrition Examination Survey, conducted from 2013 to 2015. Methods: In all, 4945 participants (2543 male and 2402 female) were included after excluding subjects using the following criteria: <19 years of age, free T4 level outside the normal range, history of thyroid disease, or incomplete data. The population was classified into three groups: short sleeper (<7 h/day), normal sleeper (7–8 h/day), and long sleeper (>8 h/day). The odds ratio (OR) for subclinical hypothyroidism or hyperthyroidism according to sleep duration was evaluated. Results: The short, normal, and long sleeper groups consisted of 2097, 2514, and 334 subjects, respectively. On multiple logistic regression analysis, compared to normal sleepers, short sleepers showed a significantly increased risk of subclinical hyperthyroidism (OR 1.37, 95% confidential interval (CI) 1.02–1.84, p = 0.036), while the risk of subclinical hypothyroidism in short sleepers was not elevated. Comparing long sleepers to normal sleepers, the OR for subclinical hyperthyroidism and hypothyroidism was 1.79 (95% CI 1.12–2.86, p = 0.015) and 1.91 (95% CI 1.03–3.53, p = 0.039), respectively. Conclusions: Both shorter and longer sleep durations were associated with an increase in the risk of subclinical thyroid dysfunction compared to the optimal sleep duration. This analysis of representative population data shows that sleep duration could intertwine with thyroid function resulting in increased risk of subclinical thyroid dysfunction. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
196. High Normal Range of Free Thyroxine is Associated with Decreased Triglycerides and with Increased High-Density Lipoprotein Cholesterol Based on Population Representative Data.
- Author
-
Lee, Jeongmin, Ha, Jeonghoon, Jo, Kwanhoon, Lim, Dong-Jun, Lee, Jung-Min, Chang, Sang-Ah, Kang, Moo-Il, and Kim, Min-Hee
- Subjects
- *
HIGH density lipoproteins , *THYROXINE , *TRIGLYCERIDES , *BLOOD cholesterol - Abstract
Background: We aimed to evaluate the association between thyroid hormone (free thyroxine, free T4) level and lipid profiles in nationally representative data. Methods: This study was based on cross-sectional survey data from the sixth Korea National Health and Nutrition Examination Survey IV. After exclusion of subjects with a history of thyroid disease or abnormal thyroid function test and those on medication for dyslipidemia and/or cardiovascular disease, a total of 3548 subjects were included in the study. Results: There was a significant decrease in serum triglyceride levels and increase in serum high-density lipoprotein (HDL) cholesterol levels with high free T4 quartiles after adjustment for confounding factors (p for trend = 0.001 and p for trend = 0.014, respectively). Risk of hypertriglyceridemia was significantly decreased (odds ratio of 0.72 (95% confidential interval 0.53–0.98)) in the highest free T4 quartile compared to the lowest free T4 quartile, p = 0.044). Conclusions: Serum free T4 levels within normal range negatively correlated with serum triglyceride level and positively correlated with HDL-cholesterol level. Therefore, a close surveillance in terms of lipid profiles could be considered in subjects with low normal serum free T4 levels. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
197. CYFRA 21-1 in Lymph Node Fine Needle Aspiration Washout Improves Diagnostic Accuracy for Metastatic Lymph Nodes of Differentiated Thyroid Cancer.
- Author
-
Lee, Jeongmin, Park, Hye Lim, Jeong, Chan-Wook, Ha, Jeonghoon, Jo, Kwanhoon, Kim, Min-Hee, Han, Jeong-Sun, Lee, Sohee, Bae, Jaseong, Jung, Chan Kwon, Jung, So Lyung, Kang, Moo Il, and Lim, Dong-Jun
- Subjects
- *
METASTASIS , *THYROID gland tumors , *BIOMARKERS , *GLOBULINS , *NEEDLE biopsy , *TUMOR markers , *PREDICTIVE tests , *SENTINEL lymph nodes , *SENTINEL lymph node biopsy , *DIAGNOSIS - Abstract
Fine needle aspiration cytology (FNAC) and washout thyroglobulin (Tg) measurements are the standard for evaluating a metastatic lymph node (LN) in thyroid cancer. However, patients rarely benefit from these procedures due to false results. This study aims to identify a reliable biomarker that significantly improves the diagnosis of metastatic LNs, in addition to FNAC and washout Tg. This study analyzed 130 LNs that were suspected to have metastases on thyroid ultrasonography, from June 2016 to December 2017. All subjects underwent FNAC, washout Tg measurements and a new biomarker, washout Cytokeratin fragment 21-1 (CYFRA 21-1) measurement. The final LN outcomes were confirmed by surgical histology, repeat FNAC, or follow-up image. The diagnostic values of the presence of washout CYFRA 21-1 for diagnosing metastatic LNs were evaluated according to final LN outcomes. Among the 130 LNs, 42 were metastatic lesions and 88 were benign. The washout CYFRA 21-1 levels were significantly higher in metastatic LNs than in benign LNs. In contrast to the findings of washout Tg, washout CYFRA 21-1 showed little overlap between benign and malignant LNs, and its diagnostic cutoff values were not affected by surgery. The combinations of FNAC and washout CYFRA 21-1 showed higher sensitivity (91.9%), specificity (96.5%), negative predictive value (98.8%), and diagnostic accuracy (94.2%) than FNAC with washout Tg. The combination of FNAC, washout Tg, and washout CYFRA 21-1 showed the best sensitivity (98.8%). When washout CYFRA 21-1 was applied to the discordant results that were observed between FNAC and washout Tg, 20 of 22 LNs were correctly diagnosed. Washout CYFRA 21-1 measurements in thyroid LNs provide a diagnostic modality. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
198. Male-specific association between subclinical hypothyroidism and the risk of non-alcoholic fatty liver disease estimated by hepatic steatosis index: Korea National Health and Nutrition Examination Survey 2013 to 2015.
- Author
-
Lee, Jeongmin, Ha, Jeonghoon, Jo, Kwanhoon, Lim, Dong-Jun, Lee, Jung-Min, Chang, Sang-Ah, Kang, Moo-Il, Cha, Bong-Yun, and Kim, Min-Hee
- Abstract
Non-alcoholic fatty liver disease (NAFLD) is a prevalent liver disease encompassing a broad spectrum of pathologic changes in the liver. Metabolic derangements are suggested to be main causes of NAFLD. As thyroid hormone is a main regulator of energy metabolism, there may be a link between NAFLD and thyroid function. In previous studies, the association between NAFLD and thyroid function was not conclusive. The aim of this study was to clarify the relationship between NAFLD and thyroid function, focusing on subclinical hypothyroidism, using nationwide survey data representing the Korean population. NAFLD was defined as a hepatic steatosis index of 36 or higher. Based on the analysis of nationwide representative data, subclinical hypothyroidism was related to a high risk of NAFLD in males, but not in females. Our study showed that thyroid function might play a substantial role in the development of NAFLD, especially in males. Further study to elucidate the underlying mechanism of gender specific association of mild thyroid dysfunction and NAFLD would be required. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
199. Persistence with Denosumab in Male Osteoporosis Patients: A Real-World, Non-Interventional Multicenter Study.
- Author
-
Jeong C, Lee J, Kim J, Ha J, Jo K, Lim Y, Kim MK, Kwon HS, Sohn TS, Song KH, Kang MI, and Baek KH
- Subjects
- Humans, Male, Medication Adherence, Republic of Korea, Treatment Outcome, Middle Aged, Aged, Aged, 80 and over, Retrospective Studies, Denosumab therapeutic use, Osteoporosis drug therapy, Bone Density Conservation Agents therapeutic use
- Abstract
Backgruound: Persistence with denosumab in male patients has not been adequately investigated, although poor denosumab persistence is associated with a significant risk of rebound vertebral fractures., Methods: We retrospectively evaluated 294 Korean male osteoporosis patients treated with denosumab at three medical centers and examined their persistence with four doses of denosumab injection over 24 months of treatment. Persistence was defined as the extent to which a patient adhered to denosumab treatment in terms of the prescribed interval and dose, with a permissible gap of 8 weeks. For patients who missed their scheduled treatment appointment(s) during the follow-up period (i.e., no-shows), Cox proportional regression analysis was conducted to explore the factors associated with poor adherence. Several factors were considered, such as age, prior anti-osteoporotic drug use, the treatment provider's medical specialty, the proximity to the medical center, and financial burdens of treatment., Results: Out of 294 male patients, 77 (26.2%) completed all four sequential rounds of the denosumab treatment. Out of 217 patients who did not complete the denosumab treatment, 138 (63.6%) missed the scheduled treatment(s). Missing treatment was significantly associated with age (odds ratio [OR], 1.03), prior bisphosphonate use (OR, 0.76), and prescription by non-endocrinologists (OR, 2.24). Denosumab was stopped in 44 (20.3%) patients due to medical errors, in 24 (11.1%) patients due to a T-score improvement over -2.5, and in five (2.3%) patients due to expected dental procedures., Conclusion: Our study showed that only one-fourth of Korean male osteoporosis patients were fully adherent to 24 months of denosumab treatment.
- Published
- 2023
- Full Text
- View/download PDF
200. Effect of Romosozumab on Trabecular Bone Score Compared to Anti-Resorptive Agents in Postmenopausal Women with Osteoporosis.
- Author
-
Jeong C, Kim J, Lim Y, Ha J, Kang MI, and Baek KH
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.